WHO ICTRP trial
We aim to conduct a 12-week double-blind placebo-controlled study for the…
CTRI/2023/04/051913 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/04/051913 |
|---|---|
| Public title | We aim to conduct a 12-week double-blind placebo-controlled study for the efficacy of Greater occipital nerve blockade (GONB) using lidocaine alone and with steroid (methylprednisolone) in chronic migraine. |
| Scientific title | GREATER OCCIPITAL NERVE BLOCK WITH AND WITHOUT STEROIDS FOR CHRONIC MIGRAINE (GONBLOCK-FOR-CM): A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY - GONBLOCK-FOR-CM |
| Primary sponsor | GB Pant Institute of Post Graduate Medical Education and Research |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: G437- Chronic migraine without aura |
| Interventions | Intervention1: Greater occipital nerve block using methylprednisolone and lignocaine : The site of injection shall be marked i.e. approximately two thirds of the distance on a line drawn from the center of the mastoid to the external… |
| Registration date | Apr 24, 2023 |
| Target size | 330 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: